Clinical Study Results
How has this study helped patients and
researchers?
This study helped researchers learn more about using durvalumab alone and durvalumab
together with tremelimumab to help patients who have advanced or metastatic non-small-cell
lung cancer.
Researchers look at the results of many studies to decide which treatments work best and are
safest. This summary shows only the main results from this one study. Other studies may provide
new information or different results.
Further clinical studies with durvalumab and tremelimumab are ongoing and planned.
15